Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37bb84c5540e6b22a978d33805974819 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5b45dec9f16481abaac58da81a21539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_487c10f25f1f69bd305198f5b10f7886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d77f11cbff4285d502ea292a3c6918e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fadc18369dac6778fe6217aed49ada7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6482a7475a20dfbd8f1f803da1ad978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63f293fb56e28b0c797fd31eb8c33ad4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
filingDate |
2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb24e156dca2a9c6739fc434ab727a02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_093078d480a530b4c5263ba8cc743d5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c011d673c3f87c44d2956090414cc656 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1aa35712473b8a6394b2bf69252c26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9c942c8e2aaa4f2223d92ff22622b4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ed9c53674f659b467f67139bb05ad7 |
publicationDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008137809-A2 |
titleOfInvention |
[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof |
abstract |
The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8987285-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013252979-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011137459-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103339126-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013544271-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012072824-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013165459-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011088152-A1 |
priorityDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |